Evidence map›Paper›PMID 40182662›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2025

Development of a Predictive Model for Classifying Immune Checkpoint Inhibitor-Induced Liver Injury Types.

Jun Kitadai, Toshifumi Tada, Takanori Matsuura, Mayumi Ehara, Tatsuya Sakane, Miki Kawano, Yuta Inoue, Shoji Tamura, Aya Horai, Yuuki Shiomi and 2 more

Abstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jun KitadaiDivision of Gastroenterology, Department of Internal Medicine Kobe University Graduate School of Medicine Hyogo Japan.
Toshifumi TadaDivision of Gastroenterology, Department of Internal Medicine Kobe University Graduate School of Medicine Hyogo Japan.ORCID https://orcid.org/0000-0002-0976-6761
Takanori MatsuuraDivision of Gastroenterology, Department of Internal Medicine Kobe University Graduate School of Medicine Hyogo Japan.
Mayumi EharaDivision of Gastroenterology, Department of Internal Medicine Kobe University Graduate School of Medicine Hyogo Japan.
Tatsuya SakaneDivision of Gastroenterology, Department of Internal Medicine Kobe University Graduate School of Medicine Hyogo Japan.
Miki KawanoDivision of Gastroenterology, Department of Internal Medicine Kobe University Graduate School of Medicine Hyogo Japan.
Yuta InoueDivision of Gastroenterology, Department of Internal Medicine Kobe University Graduate School of Medicine Hyogo Japan.
Shoji TamuraDivision of Gastroenterology, Department of Internal Medicine Kobe University Graduate School of Medicine Hyogo Japan.
Aya HoraiDivision of Gastroenterology, Department of Internal Medicine Kobe University Graduate School of Medicine Hyogo Japan.
Yuuki ShiomiDivision of Gastroenterology, Department of Internal Medicine Kobe University Graduate School of Medicine Hyogo Japan.
Yoshihiko YanoDivision of Gastroenterology, Department of Internal Medicine Kobe University Graduate School of Medicine Hyogo Japan.ORCID https://orcid.org/0000-0002-5177-7480
Yuzo KodamaDivision of Gastroenterology, Department of Internal Medicine Kobe University Graduate School of Medicine Hyogo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Immune checkpoint inhibitors (ICIs) have transformed cancer therapy; however, they are associated with ICI-induced liver injury (ICI-LI), which manifests as hepatocellular, mixed, or cholestatic patterns with variable treatment responses. This study aimed to develop and validate a predictive model to identify ICI-LI type using clinical data available at ICI initiation. Methods: A retrospective analysis of 297 patients with ICI-LI was conducted. Baseline clinical data were analyzed using univariate and multivariate logistic regression to predict ICI-LI types in the training and validation cohorts. A predictive model was developed and validated using receiver operating characteristic (ROC) curve analysis. Results: Multivariate analysis in the training cohort identified male sex (odds ratio [OR]: 3.33, 95% confidence interval [CI]: 1.57-7.06, Conclusion: This predictive model demonstrates its utility in classifying ICI-LI types.

Indexed as

immune checkpoint inhibitor‐induced liver injuryimmune checkpoint inhibitorsimmune‐related adverse eventspredictive modeltreatment management

Identifiers

PMID40182662
PMCPMC11966236

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.